Related Experiment Video
Updated: Apr 10, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy
1Intractable Disease Care Center, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto 390-8621, Japan. anakamu@shinshu-u.ac.jp.
Insights
X-linked dilated cardiomyopathy (XLDCM), a heart condition from Duchenne muscular dystrophy (DMD) gene mutations, causes lethal heart failure in young individuals. Understanding XLDCM
Area of Science:
- Cardiology
- Genetics
- Neuromuscular Disorders
Background:
- X-linked dilated cardiomyopathy (XLDCM) is a specific dystrophinopathy phenotype.
- It involves significant cardiac issues without apparent skeletal muscle weakness.
- XLDCM stems from mutations in the Duchenne muscular dystrophy (DMD) gene.
Purpose of the Study:
- To clarify the relationship between DMD gene mutations and cardiomyopathy.
- To explore potential mechanisms underlying XLDCM development.
- To emphasize the need for focused research on XLDCM pathogenesis and treatment.
Main Methods:
- This abstract does not detail specific experimental methods.
- It reviews existing knowledge on dystrophinopathies and cardiac involvement.
- It discusses hypothetical mechanisms linking DMD mutations to heart failure.
Main Results:
- XLDCM leads to fatal heart failure in affected individuals, typically between ages 10 and 20.
- Becker muscular dystrophy, an allelic disorder, can also present with dilated cardiomyopathy.
- The exact link between DMD mutations and cardiomyopathy remains incompletely understood.
Conclusions:
- XLDCM underscores the critical need for dedicated research into cardiomyopathy mechanisms and treatments.
- While therapies for severe DMD show promise, XLDCM requires specific attention.
- Further investigation into dystrophin isoforms and pathophysiological pathways is essential.
Abstract:
X-linked dilated cardiomyopathy (XLDCM) is a distinct phenotype of dystrophinopathy characterized by preferential cardiac involvement without any overt skeletal myopathy. XLDCM is caused by mutations of the Duchenne muscular dystrophy (DMD) gene and results in lethal heart failure in individuals between 10 and 20 years. Patients with Becker muscular dystrophy, an allelic disorder, have a milder phenotype of skeletal muscle involvement compared to Duchenne muscular dystrophy (DMD) and sometimes present with dilated cardiomyopathy. The precise relationship between mutations in the DMD gene and cardiomyopathy remain unclear. However, some hypothetical mechanisms are being considered to be associated with the presence of some several dystrophin isoforms, certain reported mutations, and an unknown dystrophin-related pathophysiological mechanism. Recent therapy for Duchenne muscular dystrophy, the severe dystrophinopathy phenotype, appears promising, but the presence of XLDCM highlights the importance of focusing on cardiomyopathy while elucidating the pathomechanism and developing treatment.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Satellite Stem Cells and Muscular Dystrophy
Sex-linked Disorders

